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Modeling Host-Microbiome Interactions in Caenorhabditis elegans
TEKLU K. GERBABA,1 LUKE GREEN-HARRISON,2 AND ANDRE G. BURET2
Abstract: The microbiome influences host processes including nutritional availability, development, immunity, and behavioral
responses. Caenorhabditis elegans is a powerful model to study molecular mechanisms of host–microbial interactions. Recent efforts
have been made to profile the natural microbiome of C. elegans, laying a foundation for mechanistic studies of host–microbiome
interactions in this genetically tractablemodel system. Studies using single-species microbes, multi-microbial systems, and humanized
worm–microbiome interaction studies reveal metabolic and microbial–microbial interactions relevant in higher organisms. This
article discusses recent developments in modeling the effects of host–microbiome interactions in C. elegans.
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Recent advances in sequencing technologies have
enabled an unprecedented view of the composition and
diversity of the human microbiome (Consortium of the
Human Microbiome Project, 2012). Our body organs
including those previously thought to be sterile (e.g.,
breast, lung) are colonized by microbes (Morris et al.,
2013; Urbaniak et al., 2014). Research findings impli-
cate the microbiome in most if not all aspects of host
biological processes ranging from metabolism, develop-
ment, and immunity to behavioral responses (Belkaid
and Hand, 2014; Nieuwdorp et al., 2014; Kostic et al.,
2015; Rogers et al., 2016). Significant strides have been
made in understanding the composition and diversity
of the microbiome, but much remains to be done to
characterize functions of selected members of the
microbiome. The dynamic interactions between host,
microbiome, and environment, and the implications
that these interactions have on host health and disease
are just beginning to be unraveled. Functional char-
acterization of the microbiome and its causal re-
lationship with malfunctions in mammalian model
systems is faced with cost, logistics, and inherent bi-
ological complexity challenges. Caenorhabditis elegans is
one of the simplest multicellular model organisms that
has been developed to investigate different biological
processes including development, neurobiology, host–
pathogen interactions, and aging, to name a few (Sifri
et al., 2005; Harrington et al., 2010; Marsh and May,
2012; Cohen and Troemel, 2015; Tissenbaum, 2015).
RNAi, mutant libraries, transparent imaging, tran-
scriptomics, and proteomics are well established for
mechanistic and systems biology studies in C. elegans.
The ease of maintenance of germ-free worms, high-
throughput applicability, and their relatively short
lifespan makes C. elegans a practical choice to study
interactions between host, microbiome, and the envi-
ronment (Kaletta and Hengartner, 2006; Cabreiro and
Gems, 2013; Clark and Hodgkin, 2014; Yilmaz and
Walhout, 2014). The simplicity of laboratory growth
and maintenance of germ-free worms for use in host–
microbe interaction studies is summarized in Fig. 1.
In this article, we review recent developments in
microbiome research in the C. elegans model system,
including the use of humanized worms for modeling
host–microbiome interactions and provide future di-
rections for the study of mechanisms of interactions
between host, microbiome, and the environment. We
emphasize interactions between microbes and the host
that may also benefit C. elegans as reviews on host–
pathogen interactions in C. elegans have been recently
published (Irazoqui et al., 2010; Pukkila-Worley and
Ausubel, 2012; Balla and Troemel, 2013; Clark and
Hodgkin, 2014; Ermolaeva and Schumacher, 2014;
Cohen and Troemel, 2015; Sorathia and Rajadhyaksha,
2016). Clark and Hodgkin (2014) also summarize in-
sights learned from modeling the effects of human
commensal and probiotic bacteria in C. elegans. We also
refer readers to a recent review by Zhang et al. (2017)
that summarizes findings on the natural microbiome of
C. elegans in a new meta-analysis.
THE NATURAL MICROBIOME OF C. ELEGANS
Composition and diversity
In nature, C. elegans can be found in soil and
microorganism-rich rotting fruit and plant matter (Petersen
et al., 2014). Very few earlier studies explored the as-
sociation between C. elegans and microbes in nature
(Grewal, 1991; Grewal and Wright, 1992; Venette and
Ferris, 1998; Avery and Shtonda, 2003). Driven by the
recent surge of interest in the microbiome and ad-
vances in sequencing technologies, more comprehen-
sive attempts have been made to profile the natural
microbiome of C. elegans using both culture and 16S
rDNA sequencing (Montalvo-Katz et al., 2013; Berg
et al., 2016a; Dirksen et al., 2016; Niu et al., 2016;
Samuel et al., 2016). Two different approaches were
used to characterize the worm microbiome. In the first
approach, germ-free worms were exposed to laboratory-
simulated natural environments (soil, rotten plant
matter, or soil supplemented with rotten plant matter)
to allow for the assembly of microbiome in the intestine
of the worm. In the second approach, worm strains were
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collected from the wild, and their native microbiome
characterized. Montalvo-Katz et al. (2013) used culture-
dependent approaches to identify the worm micro-
biome by growing wild-type larvae of C. elegans in soil
amended with compost or rotting fruits. Seventeen
bacterial species were isolated and identified, mainly
belonging to Bacillus and Pseudomonas genera. Culture-
dependent approaches select for culturable microbes
and hence limit the depth of diversity and composition
characterization of the microbiome. Dirksen et al.
(2016) used 16S rDNA deep sequencing to characterize
the natural microbiomes of C. elegans, Caenorhabditis
remanei, and Caenorhabditis briggsae isolated from natural
environments, including plant stems, fruit, and com-
post. The study revealed the complexity of native gut
microbial taxa of nematodes obtained from natural
environments. Although Proteobacteria is the most
dominant bacteria taxa belonging to Bacteroidetes,
Actinobacteria and Firmicutes are also represented in
this microbiome (Dirksen et al., 2016). Berg et al.
(2016a) characterized the microbiome of C. elegans N2
strain assembled from soil supplemented with plant
matter (bananas, potatoes, oranges, or strawberries). A
recent report offers an exhaustive survey of bacterial
communities inhabiting C. elegans natural environments,
rotten fruits (apples, orange, cactus fruit, and black
bryony) and a vector (snail), using culture-dependent and
culture-independent approaches (Samuel et al., 2016).
The C. elegans environment harbors dominant bacterial
taxa belonging to Proteobacteria, Firmicutes, Bacter-
iodetes, and Actinobacteria. More than 500 bacterial
isolates have been obtained from these environments
and exhaustively analyzed to determine the effects of
single, paired, and multispecies bacterial community
on worm growth (Samuel et al., 2016). Researchers
commonly use C. elegans in monoxenic association
with single-species bacteria. The studies discussed
previously revealed that the C. elegans microbiome is
not as simple as originally thought. Indeed, diverse
groups of bacteria are found associated with C. elegans
in its natural environment.
Microbiome assembly: effects of host genotype and development
stage
The association between C. elegans and its microbes is
much more than a dietary relationship. The C. elegans
microbiome is distinct from the microbiome in its en-
vironment and from the microbiome of C. remanei
(Dirksen et al., 2016). The microbiomes of C. elegans
and C. briggsae protect each species against infections,
but the microbiome of one species fails to protect the
other species (Berg et al., 2016b). The reason for the
lack of cross protection is not clear, and phylogenetic
distinctions between the microbes of the two species
using 16s rDNA analysis are not available. Although 16s
rDNA and phylogenetics-based microbiome charac-
terization allow in-depth characterization of the com-
plexity and diversity of microbial ecosystems, these
methodologies are not always able to assign all oper-
ational taxonomic units to distinct species level,
a hurdle in understanding functional contributions at
species and strain levels. Functional characterization
of microbial isolates in C. elegans should help reveal
differential contributions of closely related species/
strains as well as functional redundancy between dis-
tinct bacterial taxa. The composition and diversity of
the microbiome in the environment correlates with
developmental stages of the worms (Dirksen et al.,
2016). Alpha-Proteobacteria–rich environments support
proliferation, whereas higher levels of gamma-Proteo-
bacteria and Bacteoidetes promote nonproliferating
dauer-stage development (Samuel et al., 2016). The use
of defined synthetic microbiota ecosystems, guided by
the natural history of C. elegans, should help optimize
the development of a relevant model system for host–
microbiome interaction studies (Samuel et al., 2016).
FIG. 1. Laboratory growth and maintenance of Caenorhabditis elegans for use in host–microbe interaction studies. Gravid adult worms are
transferred to a nematode growth medium agar plate previously seeded with OP50 Escherichia coli, a standard food source for C. elegans. (1) The
worms will reproduce and populate the plate. (2) Gravid adult worms from the plate can then be transferred to a new plate (3) continuing the
cycle. When there are enough eggs and gravid adults on the plate, they can be collected, transferred to a tube, and treated with bleach, which
dissolves the worms and kills bacteria, leaving only the bleach-resistant eggs. (4) The eggs are washed and allowed to hatch and arrest at the L1
developmental stage in S-basal buffer, creating an age-synchronized germ-free population. (5) L1 worms are then resuspended in S-basal
complete media, fed OP50 E. coli, and allowed to develop over 2 to 3 d to L4/adult worms. (6) These worms are ready for host–microbe
interaction studies (7) as in Gerbaba et al. (2015).
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The genotype and development of worms appear to have
been shaped at least in part by host–microbiome in-
teractions. However, further studies into the interactions
between C. elegans and its natural microbiome are re-
quired to provide conclusive evidence on the micro-
biome impact on the host genotype.
Few attempts have been made to explore micro-
biome of other nematodes. For a recent review on the
microbiota of parasitic nematodes and the reciprocal
interactions between host microbiota and parasitic
nematodes, we refer the readers to Midha et al. (2017).
The environment in the host organism appears to in-
fluence the composition of the microbiome of parasitic
nematodes. Bacteria identified from Ascaris suum ap-
pear to have been derived from the host intestine (Hsu
et al., 1986). Adult Heligmosomoides polygyrus bakeri mi-
crobiota shows similarity to that of its murine host il-
eum (Walk et al., 2010). It is unknown if host-associated
parasitic nematodes have less or more diverse micro-
biota compared with free-living forms. Further studies
on the microbiome of parasitic nematodes using cul-
ture-independent approaches should shed light on the
impact of selective pressures from their mammalian
host. Understanding the interactions between parasitic
nematodes and their native microbiome may open up
new avenues for therapeutics. A good example for this
is the interaction between filarial worms and their
endosymbiont gram-negative intracellular bacterium,
Wolbachia. Wolbachia is necessary for normal larval
growth and development, embryogenesis, and survival
of adult filarial worms (Taylor et al., 2005), and at-
tempts are being made to target Wolbachia for the
treatment of filarial infection (Taylor et al., 2014).
Simplified host–microbiome interaction models: Escherichia
coliOP50, a uracil auxotroph of an E. coli B strain, serves
as a standard food source for C. elegans in the laboratory
(Stiernagle, 2006). It also has non-dietary benefits and
age-dependent pathogenic effects. Escherichia coli accu-
mulates in the intestine of older worms, which appears
associated with decreased lifespan, and antibiotics or
UV-treated bacteria extend worm lifespan (Gems and
Riddle, 2000; Garigan et al., 2002; Herndon et al., 2002;
McGee et al., 2011). Association of C. elegans with
a single bacterial species such as E. coli serves as a sim-
plified model to study the role of host–microbiome
interactions at the molecular level, which allows to
characterize effects of microbial factors and host path-
ways on various biological processes as discussed in the
later paragraphs (summarized in Fig. 2).
Development and aging
Bacterial signals affect worm development and aging.
Escherichia coli folate synthesis reduces C. elegans lifespan
(Virk et al., 2016). Comamonas aquatica produces
FIG. 2. Host–microbe interactions in Caenorhabditis elegans. This figure summarizes host–microbe interactions in C. elegans discussed in the
present review. Bacteria metabolic signals, such as folate, vitamin B12, tryptophan, methionine, nitric oxide (NO), cyclic antimicrobial peptide
(AMP), and amyloid protein, influence various biological processes including germ cell proliferation, development, longevity, and neuro-
degeneration in C. elegans. Expression of folate receptors (FOR1) in C. elegans is essential to the modulatory effects of bacterial folate on germ
cell proliferation. The nuclear hormone receptor (NHR-23) is likely involved in regulating the molting cycle during larval development
(MacNeil et al., 2013), but the link between the effects of Caenorhabditis aquaticus vitamin B12 on the acceleration of development and NHRs is
not clear (Watson et al., 2014). The effects of Escherichia coli HB101 on worm development (speeding growth) are target of rapamycin (TOR)
dependent (MacNeil et al., 2013). Escherichia coliHT115 tryptophan mediates detoxification responses in nhr-114 mutant worms. Microbes are
important sources of dietary methionine in C. elegans, and interference with microbial methionine synthesis induces methionine restriction,
which in turn extends lifespan (Cabreiro et al., 2013). Bacillus subtilis NO extends worm lifespan, which is dependent on DAF-16 and HSF-1
transcription factors (Gusarov et al., 2013; Donato et al., 2017). Several studies using C. elegans have illustrated how the host microbiome may
protect against pathogens (shown in dark red). Pseudomonas mendocina, Lactobacillus acidophilus, and Lactobacillus casei protect against pathogenic
infection in a PMK-1 (p38 MAPK) or b-catenin signaling (BAR1) dependent manner. Lactobacillus reuteri protects against enterotoxigenic E. coli
(ETEC) possibly through induction of expression of AMP genes. Bacillus megaterium–mediated protection against Pseudomonas infection is
linked to impaired egg laying, the potential host response pathways involved remain obscure. Various lactic acid bacteria (LAB) alter expression
of obesity phenotype genes (in green). Bacterial metabolite effects in eliciting neurodegeneration (light blue) have also been studied in C.
elegans, but the specific bacterial metabolites implicated in these effects require further identification. The effects of C. elegans-microbial
interactions on longevity, development, and germ cell proliferation are shown in orange.
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vitamin B12 that affects C. elegans development and
fertility and also breaks down propionic acid to prevent
its toxic buildup (Watson et al., 2014). Escherichia coli
HT115 tryptophan metabolism prevents sterility in
nuclear receptor nuclear hormone receptor (NHR-
114) mutant worms (Gracida and Eckmann, 2013b).
NHR-144 deficient worms grown on a B strain bacteria
such as OP50 and BL21 E. coli are sterile unless sup-
plemented with tryptophan (Gracida and Eckmann,
2013a). Bacterial signals affect the role of the mecha-
nistic target of rapamycin complex 2 (mTORC2) and
serum- and glucocorticoid-regulated kinase 1 (SGK-1)
pathway in aging. mTORC2 directs SGK-1 to inhibit
SKN-1 and release of this inhibition depends on bacte-
rial cues, which allows SKN-1 to increase stress resistance
and lifespan (Mizunuma et al., 2014). Bacillus subtilis
produces nitric oxide, which extends C. elegans lifespan
through expression of heat shock and stress response
genes controlled by DAF-16 and HSF-1 transcription
factors (Gusarov et al., 2013; Donato et al., 2017).
Neurodegenrative disorders
The simplicity of the C. elegans model system allows
the study of molecular pathways that are not easily trac-
table in higher organisms such as that of Parkinson’s
disease (Harrington et al., 2010). To study microbe-
mediated neurodegeneration, human alpha-synuclein
(AS) expressed in wild-type worms was used to analyze
effects of E. coli amyloid protein curli on AS aggregation
(Chen et al., 2016). Curli-producing bacteria fed AS-
expressing C. elegans had enhanced AS aggregation,
suggesting that bacterial amyloid functions may trigger
AS aggregation. Studies also reported on the effects of
Streptomyces venezuelae metabolites in combination with
Parkinson’s disease susceptibility gene mutations in
eliciting neurodegeneration (Ray et al., 2014; Watkins
et al., 2016). Streptomyces venezuelae metabolites cause
excessive production of reactive oxygen species, upregu-
late mitochondrial unfolded protein response pathway,
and impair ATP production, which may in part be re-
sponsible for neurotoxicity and cell death (Ray et al.,
2014).
Genetics of host–microbiome interactions
Caenorhabditis elegans is suitable to study effects of
host–microbiome interactions in a semi-highthroughput
manner. A combination of C. elegans and bacterial ge-
netic screening reveal novel host–microbe interaction
mechanisms. Coolon et al. (2009) identified candidate
genes differentially regulated in response to different
bacteria isolates. Using mutations that inactivate 21 of
the identified host genes, they showed that most bacte-
ria contribute to lifespan and fitness (Coolon et al.,
2009). Khanna et al. (2016) identified 56 E. coli dele-
tion mutants that enhance dauer formation. cyaA mu-
tant bacteria defective in cyclic antimicrobial peptide
(AMP) production extends lifespan and enhances dauer
formation in an insulin-like receptor (daf-2) mutant
worms through the modulation of transforming growth
factor-beta (daf-7) signaling (Khanna et al., 2016).
Germ cell proliferation
Bacterial signals appear to modulate germ cell pro-
liferation in C. elegans. Bacteria-derived folates promote
worm germ cell proliferation independently of their
roles as vitamins, and folate receptor-1 (FOLR-1) is re-
quired for the stimulation of germ cell proliferation
(Chaudhari et al., 2016). FOLRs are overexpressed in
many human cancers and associated with neoplastic
progression and poor prognosis (Kelemen, 2006), and
studies implicate the microbiome in the development of
cancer (Schwabe and Jobin, 2013). It will be interesting to
see the potential use of C. elegans as a model to investigate
the role of the microbiome in cancer pathogenesis.
Drug resistance
Caenorhabditis elegans is a suitable model to study
pathogenic nematode drug resistance and it has been
used for screening antihelminthics (Geary and
Thompson, 2001; Burns et al., 2015). The role of the
host gut microbiome in the development of drug re-
sistance in pathogenic nematodes remains unclear.
Thirty gut Enterobacteriaceae that catabolize benz-
imidazole-class antihelminthics have been isolated and
tested for their effects on C. elegans survival in the
presence of benzimidazoles (Whittaker et al., 2016).
The Enterobacteriaceae microbiota protects C. elegans
from benzimidazoles and adult ascarids from the effects
of albendazole (Whittaker et al., 2016). Research on
clinical interactions between gastrointestinal helminths
and resident microbiota during drug treatment is im-
portant in attempts to understand interactions between
human parasite nematodes and the microbiome. By
taking into account the importance of the microbiome,
drug screening and resistance studies in C. elegans may
help devise novel approaches to curb resistance to an-
timicrobials and antihelminthics.
Survival assays and functional screening
The single-species microbe–host interaction model
system is instrumental in understanding the function of
specific members of the microbiome. Beneficial and
detrimental microbes can be screened in a relatively
short time using worm survival as a readout. Samuel
et al. (2016) studied the response of C. elegans to 565
bacterial species isolated from C. elegans natural envi-
ronment (Samuel et al., 2016). These studies showed
that 78% of the bacterial isolates had beneficial effects
on survival, whereas the remaining 22% of the bacterial
strain had detrimental effects.
Fat metabolism
Microbiome dominated with Firmicutes rather than
Bacteriodetes have been associated with obesity in humans
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(Turnbaugh et al., 2006; Turnbaugh and Gordon, 2009;
Turnbaugh et al., 2009a). A consortium of Lactobacillus
delbrueckii, Lactobacillus fermentum, and Leuconostoc lactis af-
fect energy metabolism in C. elegans. The lactic acid bac-
teria (LAB) microbial consortia decrease worm lifespan
when compared with animals fed with conventional E. coli,
cause accumulation of lipid droplets, and alter expres-
sion of obesity phenotype genes, nhr-49, pept-1, and tub-1
(Zanni et al., 2015).
Microbiome and host–pathogen interactions
Host–pathogen interaction studies in C. elegans have
allowed the study of various pathways and mechanisms
conserved in higher organisms. These studies explore
mechanisms of host–pathogen interactions to uncover
host and pathogen factors important in susceptibility
and resistance to infections. The effect of pathogens on
worm survival is used as a proxy for pathogenic effects,
as determined by feeding worms E. coli OP50 alone, or
in the presence of a pathogen of interest. The role of
microbes in protection against infection is determined
by exposing worms to members of the microbiome and
assessing the response to infecting pathogens. Mem-
bers of the C. elegans natural microbiome, Bacillus meg-
aterium and Pseudomonas mendocina, enhance worm
resistance to subsequent infection with Psudomonas
aeruginosa (Montalvo-Katz et al., 2013). The protective
microbe P. mendocina primes the immune response to
subsequent infection with the phylogenetically closely
related species P. aeruginosa. In hamsters and humans,
nontoxigenic Clostridium difficile protect against highly
virulent C. difficile infections (Seal et al., 1987; Shim
et al., 1998; Villano et al., 2012; Nagaro et al., 2013;
Gerding et al., 2015). The mechanisms are not clear
although colonization resistance through niche exclu-
sion is hypothesized to be at play (Natarajan et al., 2013;
Gerding et al., 2015). Caenorhabditis elegansmay serve as
a novel tool to study and distinguish between niche
exclusion and immune priming as mechanisms of
microbiota-mediated protection against pathogens.
Another C. elegans native microbiome member, Pseudo-
manas sp., affords protection against the C. elegans
fungal pathogen, Drechmeria coniospora (Dirksen et al.,
2016). Enterobacter cloacae, an isolate from C. elegans,
protects its host against infection with Enterococcus fae-
calis, but fails to protect a nonhost species, C. briggsae
(Berg et al., 2016b). Similar host-specific protective ef-
fects were observed for E. cloacae isolates from C. briggsae
(Berg et al., 2016b).
Caenorhabditis elegans, in its natural environment, is
exposed to diverse beneficial and detrimental mi-
crobes. Beneficial bacteria (Gluconobacter sp., Enter-
obacter sp., and Providencia sp.) isolated from natural
habitats of C. elegans have protective effects against
detrimental bacteria (Serratia sp., Pseudomonas sp., and
Chryseobacterium sp.) isolated from the same environ-
ment (Samuel et al., 2016).
Caenorhabditis elegans presents an interesting model
system to experimentally dissect the role of the micro-
biome in host evolution and adaptation to changing
environments including infections. The short lifespan
of C. elegans allows for studies on aging and co-evolution.
Ford et al. (2016) studied co-evolutionary dynamics be-
tween a defensive microbe and a pathogen driven by
fluctuating selection (Ford et al., 2016). Co-passaging
protective E. faecalis bacteria and a Staphyloccoccus aureus
pathogen results in reciprocal adaptation, revealing
patterns of pathogen local adaptation and genetic di-
versification (Ford et al., 2016). Research into compe-
tition and resilience between founder and introduced
bacteria using E. coli and S. typhymurium shows the
persistent gut colonization by Salmonella efficiently
outcompetes E. coli strains; by contrast, repeated in vivo
passage enhances the ability of E. coli to compete
(Portal-Celhay and Blaser, 2012). Caenorhabditis elegans
also allowed to investigate synergistic commensalism of
opportunistic pathogens, using Candida albicans and
gram-positive E. faecalis, both normal residents of the
human gut microbiome. Co-infection of C. elegans with
these microorganisms is less pathogenic than with ei-
ther species alone because E. faecalis derived products
inhibit hyphal morphogenesis in C. albicans (Garsin
and Lorenz, 2013).
Infection with certain pathogens is known to lead to
microbiome dysbiosis (Beatty et al., 2017), which has
been implicated in a variety of post-infectious in-
flammatory disorders in humans. Parasitic (e.g., Giar-
dia duodenalis) and bacterial (e.g., Campylobacter jejuni)
infections have been found to cause post-infectious
irritable bowel syndrome and flares in patients with
inflammatory bowel (Buret, 2016). The mechanisms
remain obscure. Studies of changes in intestinal mi-
crobiome composition and function on exposure to
enteropathogens such as G. duodenalis will improve our
understanding of the mechanisms of microbiome-
mediated post-infectious disorders. The effects of G. du-
odenalis on host–microbiome interactions in C. elegans
were recently investigated (Gerbaba et al., 2015). Giardia
secretes factors that induce functional changes in non-
pathogenic E. coli bacteria by altering expression of
a broad range of E. coli metabolic genes, possibly con-
verting them into pathobionts. Indeed, exposure to
Giardia alters expression of E. coli genes involved in cys-
teine metabolism, and concurrent exposure to both mi-
croorganisms, but not to each organism alone, causes
lethal toxicity in C. elegans (Gerbaba et al., 2015). Niu
et al. (2016) studied effects of a soil-dwelling opportu-
nistic pathogen Bacillus nematocida B16 on the relative
abundance of C. elegansmicrobiome that were assembled
from soil and rotten fruits. Although the interpretation
of parts of the data was limited in view of the lack of some
controls (non-pathogenic Bacillus), it is worthwhile to
mention here that the authors suggested that C. elegans
infection with B. nematocida B16 increases the relative
352 Journal of Nematology, Volume 49, No. 4, December 2017
abundance of Firmicutes and decreases the representa-
tion of Proteobacteria, Actinobacteria, Cyanobacteria,
and Acidobacteria (Niu et al., 2016).
The mechanisms underlying the protective roles of
members of the microbiome warrant further in-
vestigation. Protective mechanisms of bacteria have also
been studied using the C. elegans model. Lactobacillus
casei protects C. elegans from the effects of Klebsiella
pneumonia; L. casei triggers a toll-like receptor mediated
receptor for activated C kinase 1 dependent p38 MAPK
pathway to help C. elegans resist K. pneumonia infection
(Kamaladevi and Balamurugan, 2016). Heat-killed
Lactobacillus sp. enhances the survival of C. elegans ex-
posed to Salmonella sp. and Yersinia sp. Exposure to
heat-killed LAB increases the expression of genes
(acdh-1 and cnc-2) related to the defense response and
the innate immune response (Lee et al., 2015). Bacillus
subtilis, often found in the natural habitat of C. elegans,
persists in the C. elegans intestine and protects against
infection with Bacillus thuringiensis by producing fen-
gycin, a lipopeptide acting as an antibiotic (Iatsenko
et al., 2014). The C. elegans model system has proven
useful for screening protective bacteria (Iatsenko et al.,
2014; Park et al., 2014). Iatsenko et al. (2014) identified
B. subtilis GS67 strain with the strongest effect against
B. thuringiensis among eight other natural B. subtils
isolates. Park et al. (2014) identified four Lactobacillus
plantarum strains originally isolated from infant feces
that persist in the nematode gut, significantly prolong
longevity and improve worm survival upon exposure to
pathogenic S. aureus (Park et al., 2014). Another
screening study allowed the identification of LAB bac-
teria that protect against enterotoxigenic E. coli (Zhou
et al., 2014a). One of the isolates, Lactobacillus reuteri,
promotes host defensive AMP genes clec-60 and clec-85
(Zhou et al., 2014b). In addition to the aforementioned
observations, ever-increasing evidence supports the hy-
pothesis that microbial–microbial interactions determine
the outcome of infection in the host. Co-infecting mi-
croorganisms modulate gene expression in pathogens
and commensals during polymicrobial infections (Reti
et al., 2015; Ibberson et al., 2017). Identification of mi-
crobial genes that may be essential for disease production
is important for developing new therapies. The findings
discussed here illustrate the importance of studying
pathogens in the context of complex polymicrobial
communities and further underscore modeling such mi-
crobial–microbial interactions and their effect in C. ele-
gans provides a powerful testing ground for such studies.
Humanized worms and host–microbiome interactions:
Humanized mice, germ free mice transplanted with
human microbiota, are useful tools to study microbiome
function (Martin et al., 2008; Turnbaugh et al., 2009b;
Beatty et al., 2017). Humanized worms, C. elegans similarly
associated with human microbial communities, can help
model the effects of microbiome dysbiosis by systemati-
cally analyzing host, microbial, and environmental factors
important in the regulation of host–microbiome in-
teractions that modulate health and disease.
The gut microbiota undergoes significant composi-
tional and functional changes in intensive care patients.
Changes include reduced diversity in a microbiome
dominated by members of the Enterobacteriaceae and
Proteobacteria. Decreased microbiome diversity has
been associated with hospital-acquired infections such
as C. difficile and sepsis (Chang et al., 2008; McDonald
et al., 2016). Recent studies characterized the function
of such ultra-low diversity microbial communities in
patients with prolonged critical illness, where the micro-
biome was dominated by Enterococcus sp., Staphylococcus sp.
and fungal pathogens such as C. albicans and Candida
glabrata (Zaborin et al., 2014). The microbiome com-
munities behaved as commensals or pathobionts, de-
pending on their composition and environmental/host
signals. Studies using C. elegans revealed the effects of
host factors such as endogenous opioids and nutrient
deprivation in changing the phenotype of these com-
munities. Under conditions of nutrient deprivation, the
ultra-low diversity communities behave like commensals,
but opioid treatment enhances the pathogenic behavior
of these communities, which is abolished in the presence
of phosphate-polythylene glycol, an inhibitor of bacterial
virulence expression. Endogenous opioids are released
during physiologic stress and critical illness; parenteral
feeding of critically ill patients results in nutrient depri-
vation (Zaborin et al., 2014). The study by Zaborin et al.
(2014) shows the potential use of the C. elegans to model
functional changes in the microbiome of critically ill
patients by mimicking local conditions in the gut, nu-
trient deprivation and opioid release.
Recent studies using C. elegans also characterized
functional differences in the microbiome of in-
flammatory bowel disease patients collected from active
and inactive sites of the colon. Compared with the ef-
fects of microbiota from healthy donors, microbiota
from inflamed sites caused significantly greater lethal
toxicity, whereas microbiota from non-inflamed sites
did not seem to affect worm survival (Gerbaba et al.,
2015). Microbiota from inflamed sites in patients with
inflammatory bowel disease is characterized by a low
diversity microbiome (Sepehri et al., 2007). Further-
more, when concurrently exposed to G. duodenalis,
microbiota from inflamed IBD sites synergized le-
thal toxicity in C. elegans, whereas microbiota from non-
inflamed sites did not (Gerbaba et al., 2015). The
aforementioned observations indicate that studies on
the effects of human microbiome communities in hu-
manized C. elegans help shed light on the functional
significance of alterations in the human microbiome.
FUTURE DIRECTIONS
Interactions of single species microbiota isolates
(e.g., E. coli) with C. elegans represent powerful model
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systems to characterize molecular mechanisms regu-
lating host–microbial interactions. The microbiome of
C. elegans, although Proteobacteria species are dominant—
at least in the proliferative larval stage of worms—they
contain core microbiome members that are also present
in higher organisms. Studies using more complex mi-
crobial consortia are now required to model the biology
of microbial ecosystems in C. elegans. There is little
specificity in the ecology of C. elegans, with soil, rotten
fruits, and plant matter sometimes, but not always, har-
boring C. elegans. The importance of the environment in
shaping the composition of C. elegans microbiome is an
interesting area of future investigation. The simplicity of
the C. elegansmodel system should allow for a systematic
construction of defined microbial consortia that are
suitable for modeling specific biological processes. Un-
raveling pathways that regulate the microbiome in C.
elegans will help shed light on conserved evolutionary
features relevant to higher organisms, including mech-
anisms of microbial ecosystem succession. In turn, such
studies may guide the construction of synthetic micro-
bial ecosystems to maintain the homeostasis of host and
microbial ecosystem interactions. Moreover, the use of C.
elegans humanized with disease-specific microbial com-
munities will help devise strategies to manipulate the
microbiome for therapeutics. The C. elegans model is
also suitable to answer fundamental questions of how
certain pathogens overcome the protective effects of the
microbiome, and which host, microbial, and environ-
mental factors determine susceptibility and resistance to
infections.
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